LTF and hepatocellular carcinoma: The oral and intravenous administration of doxorubicin-loaded lactoferrin nanoparticles improved the efficacy and safety of doxorubicin for the treatment of hepatocellular carcinomas induced by diethylnitrosamine in rats compared to doxorubicin [81,82].